Insmed Incorporated (INSM)
$112.58 +0.89% Close Oct 30, 2026 Live
Insmed stock today
Insmed closed at $112.58 on October 30, 2026, up 0.89% on the day. Over the past year it returned -42.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $24.6 billion.
$100.00$150.00$200.00
NovJan 2026MarMayJulSep
| Period | INSM | S&P 500 (SPY) |
|---|---|---|
| 1 month | -1.4% | -0.9% |
| 3 months | +10.9% | +2.1% |
| Year to date | -35.3% | +11.7% |
| 1 year | -42.0% | +12.4% |
| 3 years | +373.0% | +88.5% |
| 5 years | +273.4% | +76.0% |
Key statistics
- Market value
- $24.6B
- Price / sales
- 16.2
- 52-week range
- $91.88 to $211.41
About Insmed
Develops inhaled and specialty pharmaceutical treatments for respiratory and infectious diseases.
Sector: Health Care · Industry: Biotechnology
More on Insmed
- Financials: revenue, earnings and segmentsRevenue +67% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $8,315 today
No forecast, no recommendation. This page describes Insmed Incorporated from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.